Literature DB >> 16352569

Mutations in the U5 sequences adjacent to the primer binding site do not affect tRNA cleavage by rous sarcoma virus RNase H but do cause aberrant integrations in vivo.

Jangsuk Oh1, Kevin W Chang, Stephen H Hughes.   

Abstract

In most retroviruses, the first nucleotide added to the tRNA primer becomes the right end of the U5 region in the right long terminal repeat (LTR); the removal of this tRNA primer by RNase H defines the right end of the linear double-stranded DNA. Most retroviruses have two nucleotides between the 5' end of the primer binding site (PBS) and the CA dinucleotide that will become the end of the integrated provirus. However, human immunodeficiency virus type 1 (HIV-1) has only one nucleotide at this position, and HIV-2 has three nucleotides. We changed the two nucleotides (TT) between the PBS and the CA dinucleotide of the Rous sarcoma virus (RSV)-derived vector RSVP(A)Z to match the HIV-1 sequence (G) and the HIV-2 sequence (GGT), and we changed the CA dinucleotide to TC. In all three mutants, RNase H removes the entire tRNA primer. Sequence analysis of RSVP(HIV2) proviruses suggests that RSV integrase can remove three nucleotides from the U5 LTR terminus of the linear viral DNA during integration, although this mutation significantly reduced virus titer, suggesting that removing three nucleotides is inefficient. However, the results obtained with RSVP(HIV1) and RSVP(CATC) show that RSV integrase can process and integrate the normal U3 LTR terminus of a linear DNA independently of an aberrant U5 LTR terminus. The aberrant end can then be joined to the host DNA by unusual processes that do not involve the conserved CA dinucleotide. These unusual events generate either large duplications or, less frequently, deletions in the host genomic DNA instead of the normal 5- to 6-base duplications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16352569      PMCID: PMC1317513          DOI: 10.1128/JVI.80.1.451-459.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Effects of mutations in the G tract of the human immunodeficiency virus type 1 polypurine tract on virus replication and RNase H cleavage.

Authors:  John G Julias; Mary Jane McWilliams; Stefan G Sarafianos; W Gregory Alvord; Eddy Arnold; Stephen H Hughes
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

2.  Base-pair substitutions in avian sarcoma virus U5 and U3 long terminal repeat sequences alter the process of DNA integration in vitro.

Authors:  P Hindmarsh; M Johnson; R Reeves; J Leis
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

3.  Small RNAs of Rous sarcoma virus: characterization by two-dimensional polyacrylamide gel electrophoresis and fingerprint analysis.

Authors:  R C Sawyer; J E Dahlberg
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

4.  Nucleotide sequences of integrated Moloney sarcoma provirus long terminal repeats and their host and viral junctions.

Authors:  R Dhar; W L McClements; L W Enquist; G F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

Review 5.  Transfer RNA into RNA tumor viruses.

Authors:  L C Waters; B C Mullin
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1977

6.  Construction and characterization of a replication-competent retroviral shuttle vector plasmid.

Authors:  Jangsuk Oh; John G Julias; Andrea L Ferris; Stephen H Hughes
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

7.  Retrovirus-specific packaging of aminoacyl-tRNA synthetases with cognate primer tRNAs.

Authors:  Shan Cen; Hassan Javanbakht; Sunghoon Kim; Kiyotaka Shiba; Rebecca Craven; Alan Rein; Karla Ewalt; Paul Schimmel; Karin Musier-Forsyth; Lawrence Kleiman
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

8.  Mutations in the 5' end of the human immunodeficiency virus type 1 polypurine tract affect RNase H cleavage specificity and virus titer.

Authors:  Mary Jane McWilliams; John G Julias; Stefan G Sarafianos; W Gregory Alvord; Edward Arnold; Stephen H Hughes
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Mutational analyses of the core domain of Avian Leukemia and Sarcoma Viruses integrase: critical residues for concerted integration and multimerization.

Authors:  Karen Moreau; Claudine Faure; Sébastien Violot; Patrice Gouet; Gérard Verdier; Corinne Ronfort
Journal:  Virology       Date:  2004-01-20       Impact factor: 3.616

10.  Using pyrrolo-deoxycytosine to probe RNA/DNA hybrids containing the human immunodeficiency virus type-1 3' polypurine tract.

Authors:  Chandravanu Dash; Jason W Rausch; Stuart F J Le Grice
Journal:  Nucleic Acids Res       Date:  2004-03-05       Impact factor: 16.971

View more
  19 in total

1.  Integration of rous sarcoma virus DNA: a CA dinucleotide is not required for integration of the U3 end of viral DNA.

Authors:  Jangsuk Oh; Kevin W Chang; Stephen H Hughes
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

Review 2.  Retroviral integrase proteins and HIV-1 DNA integration.

Authors:  Lavanya Krishnan; Alan Engelman
Journal:  J Biol Chem       Date:  2012-10-05       Impact factor: 5.157

3.  Genome-wide amplification of proviral sequences reveals new polymorphic HERV-K(HML-2) proviruses in humans and chimpanzees that are absent from genome assemblies.

Authors:  Catriona M Macfarlane; Richard M Badge
Journal:  Retrovirology       Date:  2015-04-28       Impact factor: 4.602

4.  Treatment with suboptimal doses of raltegravir leads to aberrant HIV-1 integrations.

Authors:  Janani Varadarajan; Mary Jane McWilliams; Stephen H Hughes
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-19       Impact factor: 11.205

5.  Quantitative analysis of HIV-1 preintegration complexes.

Authors:  Alan Engelman; Ilker Oztop; Nick Vandegraaff; Nidhanapati K Raghavendra
Journal:  Methods       Date:  2009-02-20       Impact factor: 3.608

6.  Mutations in the U5 region adjacent to the primer binding site affect tRNA cleavage by human immunodeficiency virus type 1 reverse transcriptase in vivo.

Authors:  Jangsuk Oh; Mary Jane McWilliams; John G Julias; Stephen H Hughes
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

7.  The effects of alternate polypurine tracts (PPTs) and mutations of sequences adjacent to the PPT on viral replication and cleavage specificity of the Rous sarcoma virus reverse transcriptase.

Authors:  Kevin W Chang; Jangsuk Oh; W Gregory Alvord; Stephen H Hughes
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

8.  Rous sarcoma virus (RSV) integration in vivo: a CA dinucleotide is not required in U3, and RSV linear DNA does not autointegrate.

Authors:  Jangsuk Oh; Kevin W Chang; Rafal Wierzchoslawski; W Gregory Alvord; Stephen H Hughes
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

9.  Fidelity of target site duplication and sequence preference during integration of xenotropic murine leukemia virus-related virus.

Authors:  Sanggu Kim; Alice Rusmevichientong; Beihua Dong; Roland Remenyi; Robert H Silverman; Samson A Chow
Journal:  PLoS One       Date:  2010-04-20       Impact factor: 3.240

10.  Structural basis of hAT transposon end recognition by Hermes, an octameric DNA transposase from Musca domestica.

Authors:  Alison B Hickman; Hosam E Ewis; Xianghong Li; Joshua A Knapp; Thomas Laver; Anna-Louise Doss; Gökhan Tolun; Alasdair C Steven; Alexander Grishaev; Ad Bax; Peter W Atkinson; Nancy L Craig; Fred Dyda
Journal:  Cell       Date:  2014-07-17       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.